Arkolith/Insider Trading/EMMA/Form 4

Lim Seah H.

DirectorEmmaus Life Sciences, Inc. (EMMA) · full profile →Form 4 · filed Sep 18, 2024
Net Buying
Open-Market Buys
$800
Open-Market Sells
$0
Net Open-Market Flow
$800
Transactions
1
1 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Sep 16, 2024Buy(P)20K$0.04$8004.6M

Transaction Codes

P
Open-market purchase

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0000950170-24-107658) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML